143 related articles for article (PubMed ID: 35637161)
1. SMYD2 epigenetically activates MEX3A and suppresses CDX2 in colorectal cancer cells to augment cancer growth.
Pan L; Fan Y; Zhou L
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):959-969. PubMed ID: 35637161
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma.
Xu Z; Liu Y; Pan Z; Qin L
Histol Histopathol; 2024 Feb; 39(2):263-277. PubMed ID: 37232506
[TBL] [Abstract][Full Text] [Related]
3. CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness.
Pereira B; Sousa S; Barros R; Carreto L; Oliveira P; Oliveira C; Chartier NT; Plateroti M; Rouault JP; Freund JN; Billaud M; Almeida R
Nucleic Acids Res; 2013 Apr; 41(7):3986-99. PubMed ID: 23408853
[TBL] [Abstract][Full Text] [Related]
4. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
5. MEX3A promotes angiogenesis in colorectal cancer via glycolysis.
Lu Y; Bi T; Zhou S; Guo M
Libyan J Med; 2023 Dec; 18(1):2202446. PubMed ID: 37155144
[TBL] [Abstract][Full Text] [Related]
6. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
7. Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy.
Chen RX; Xu SD; Deng MH; Hao SH; Chen JW; Ma XD; Zhuang WT; Cao JH; Lv YR; Lin JL; Li SY; Qiao GB; Xie D; Wang FW
Signal Transduct Target Ther; 2024 Apr; 9(1):80. PubMed ID: 38565536
[TBL] [Abstract][Full Text] [Related]
8. CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway.
Graule J; Uth K; Fischer E; Centeno I; Galván JA; Eichmann M; Rau TT; Langer R; Dawson H; Nitsche U; Traeger P; Berger MD; Schnüriger B; Hädrich M; Studer P; Inderbitzin D; Lugli A; Tschan MP; Zlobec I
Clin Epigenetics; 2018 Sep; 10(1):120. PubMed ID: 30257705
[TBL] [Abstract][Full Text] [Related]
9. Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer.
Zhang Y; Zhou L; Xu Y; Zhou J; Jiang T; Wang J; Li C; Sun X; Song H; Song J
Angiogenesis; 2023 Feb; 26(1):1-18. PubMed ID: 35503397
[TBL] [Abstract][Full Text] [Related]
10. SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.
Wu L; Kou F; Ji Z; Li B; Zhang B; Guo Y; Yang L
Cell Death Dis; 2021 May; 12(5):439. PubMed ID: 33935284
[TBL] [Abstract][Full Text] [Related]
11. Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative state.
Yang X; Li G; Tian Y; Wang X; Xu J; Liu R; Deng M; Shao C; Pan Y; Wu X; Li M; Zhang C; Liu R; Qin J; Zhang C; Liu Z; Wu X; Plikus MV; Lengner CJ; Zheng Z; Lv C; Yu Z
Theranostics; 2022; 12(16):6865-6882. PubMed ID: 36276637
[No Abstract] [Full Text] [Related]
12. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
Li LX; Zhou JX; Calvet JP; Godwin AK; Jensen RA; Li X
Cell Death Dis; 2018 Feb; 9(3):326. PubMed ID: 29487338
[TBL] [Abstract][Full Text] [Related]
13. Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro.
He S; Sun XJ; Zheng JB; Qi J; Chen NZ; Wang W; Wei GB; Liu D; Yu JH; Lu SY; Wang H
Mol Med Rep; 2015 Aug; 12(2):1838-44. PubMed ID: 25847407
[TBL] [Abstract][Full Text] [Related]
14. LIN28B induces a differentiation program through CDX2 in colon cancer.
Suzuki K; Masuike Y; Mizuno R; Sachdeva UM; Chatterji P; Andres SF; Sun W; Klein-Szanto AJ; Besharati S; Remotti HE; Verzi MP; Rustgi AK
JCI Insight; 2021 May; 6(9):. PubMed ID: 33755595
[TBL] [Abstract][Full Text] [Related]
15. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
16. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
Yan L; Li H; An W; Wei W; Zhang X; Wang L
Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
[TBL] [Abstract][Full Text] [Related]
17. The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.
Chen W; Hu L; Lu X; Wang X; Zhao C; Guo C; Li X; Ding Y; Zhao H; Tong D; Wang L; Huang C
Breast Cancer Res Treat; 2023 Oct; 201(3):353-366. PubMed ID: 37433992
[TBL] [Abstract][Full Text] [Related]
18. MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression.
Zhou X; Li S; Ma T; Zeng J; Li H; Liu X; Li F; Jiang B; Zhao M; Liu Z; Qin Y
Exp Ther Med; 2021 Nov; 22(5):1343. PubMed ID: 34630697
[TBL] [Abstract][Full Text] [Related]
19. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production.
Xu G; Liu G; Xiong S; Liu H; Chen X; Zheng B
J Biol Chem; 2015 Feb; 290(9):5414-23. PubMed ID: 25583990
[TBL] [Abstract][Full Text] [Related]
20. MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.
Li F; Zhao C; Diao Y; Wang Z; Peng J; Yang N; Qiu C; Kong B; Li Y
Cell Death Dis; 2022 Jun; 13(6):553. PubMed ID: 35715407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
